AMTI Applied Molecular Transport Inc.

Applied Molecular Transport (AMT) is a clinical-stage biopharmaceutical company that is applying its proprietary bioengineering technology platform to create transformative oral biological therapies for patients with severe autoimmune, inflammatory, liver and metabolic diseases.

As of 07/01/2022     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  06/05/2020
Outstanding shares:  38,654,163
Average volume:  356,990
Market cap:   $112,483,614
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BMFYGD5
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.88
PS ratio:   0.00
Return on equity:   -95.74%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy